Company news

Share this article:

Pharmaceutical promotion measurement firm ImpactRx has acquired Paragon Research & Consulting, Inc. of West Chester, PA. Paragon is expected to apply its analytical and custom research capabilities to ImpactRx's proprietary data to evaluate of the pharmaceutical market and of individual company and brand performance.

Teva Pharmaceutical Industries announced it has entered into a definitive agreement to acquire CoGenesys, a privately held biopharmaceutical company with a broad based biotechnology platform and focused on the development of peptide- and protein-based medicines across broad therapeutic categories. CoGenesys was established in 2005 as a division within Human Genome Sciences Inc. to focus on early drug development and was spun off as an independent company in June 2006.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.